Amylyx Pharmaceuticals (AMLX) Short Interest Ratio & Short Volume → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free AMLX Stock Alerts $1.78 -0.15 (-7.51%) (As of 01:17 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Amylyx Pharmaceuticals Short Interest DataCurrent Short Volume6,510,000 sharesPrevious Short Volume6,010,000 sharesChange Vs. Previous Month+8.32%Dollar Volume Sold Short$13.48 millionShort Interest Ratio / Days to Cover2.1Last Record DateApril 15, 2024Outstanding Shares68,010,000 sharesFloat Size46,940,000 sharesShort Percent of Float13.87%Today's Trading Volume2,363,475 sharesAverage Trading Volume2,728,543 sharesToday's Volume Vs. Average87% Short Selling Amylyx Pharmaceuticals ? Sign up to receive the latest short interest report for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAMLX Short Interest Over TimeAMLX Days to Cover Over TimeAMLX Percentage of Float Shorted Over Time Ad American Hartford Gold GroupDave Ramsey Shocks Millions With US Dollar LunacyDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE Amylyx Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,510,000 shares $13.48 million +8.3%13.9%2.1 $2.07 3/31/20246,010,000 shares $17.07 million +18.1%12.6%2 $2.84 3/15/20245,090,000 shares $16.49 million +16.5%10.7%1.8 $3.24 2/29/20244,370,000 shares $82.37 million -12.3%8.5%1.8 $18.85 2/15/20244,980,000 shares $76.59 million -8.5%9.6%4.2 $15.38 1/31/20245,440,000 shares $87.04 million -5.1%10.9%3.9 $16.00 Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,730,000 shares $90.48 million +5.3%11.5%3.9 $15.79 12/31/20235,440,000 shares $80.08 million -18.3%10.9%3.4 $14.72 12/15/20236,660,000 shares $94.77 million -4.0%13.4%4.2 $14.23 11/30/20236,940,000 shares $98.27 million -1.8%14.0%4.4 $14.16 11/15/20237,070,000 shares $92.48 million -10.8%14.2%4.7 $13.08 10/31/20237,930,000 shares $129.34 million -18.8%16.2%5.5 $16.31 10/15/20239,770,000 shares $169.22 million +11.5%19.9%7.8 $17.32 9/30/20238,760,000 shares $160.40 million -2.0%17.8%7.4 $18.31 9/15/20238,940,000 shares $176.83 million +4.2%19.1%7.8 $19.78 8/31/20238,580,000 shares $184.98 million -0.4%18.0%7.6 $21.56 8/15/20238,610,000 shares $180.81 million +1.4%18.0%7.2 $21.00 7/31/20238,490,000 shares $199.09 million +2.2%19.8%7.5 $23.45 7/15/20238,310,000 shares $188.30 million -9.5%19.4%7.8 $22.66 6/30/20239,180,000 shares $198.01 million -0.9%21.4%9.2 $21.57 6/15/20239,260,000 shares $229.28 million +5.2%21.6%9.4 $24.76 5/31/20238,800,000 shares $217.27 million +3.2%20.5%8.5 $24.69 5/15/20238,530,000 shares $240.03 million +24.2%20.1%9 $28.14 4/30/20236,870,000 shares $195.11 million +12.6%16.0%7.7 $28.40 4/15/20236,100,000 shares $183 million -4.5%14.3%6.5 $30.00 3/31/20236,390,000 shares $187.48 million +9.0%15.0%6.7 $29.34 3/15/20235,860,000 shares $196.90 million +7.3%13.8%6.6 $33.60 2/28/20235,460,000 shares $190.12 million -6.2%14.8%6.9 $34.82 2/15/20235,820,000 shares $202.42 million +1.4%15.8%7.3 $34.78 1/31/20235,740,000 shares $224.95 million +1.6%16.0%7.1 $39.19 1/15/20235,650,000 shares $211.82 million +0.2%15.7%7.1 $37.49 12/30/20225,640,000 shares $208.40 million +19.8%15.6%6.2 $36.95 12/15/20224,710,000 shares $164.94 million -2.1%13.1%4.5 $35.02 11/30/20224,810,000 shares $184.56 million -8.4%13.5%3.4 $38.37 11/15/20225,250,000 shares $186.06 million -2.1%14.7%3.3 $35.44 10/31/20225,360,000 shares $191.19 million -20.0%16.8%3.5 $35.67 10/15/20226,700,000 shares $231.42 million +15.5%21.0%4.4 $34.54 9/30/20225,800,000 shares $163.27 million +57.6%18.2%3.9 $28.15 9/15/20223,680,000 shares $113.56 million +5.4%12.1%2.9 $30.86 8/31/20223,490,000 shares $88.09 million +2.7%11.5%3.1 $25.24Dave Ramsey Shocks Millions With US Dollar Lunacy (Ad)Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE AMLX Short Interest - Frequently Asked Questions What is Amylyx Pharmaceuticals' current short interest? Short interest is the volume of Amylyx Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 6,510,000 shares of AMLX short. 13.87% of Amylyx Pharmaceuticals' shares are currently sold short. Learn More on Amylyx Pharmaceuticals' current short interest. What is a good short interest ratio for Amylyx Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMLX shares currently have a short interest ratio of 2.0. Learn More on Amylyx Pharmaceuticals's short interest ratio. Which institutional investors are shorting Amylyx Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amylyx Pharmaceuticals: Concourse Financial Group Securities Inc., ADAR1 Capital Management LLC, and Worth Venture Partners LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Amylyx Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.87% of Amylyx Pharmaceuticals' floating shares are currently sold short. Is Amylyx Pharmaceuticals' short interest increasing or decreasing? Amylyx Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 6,510,000 shares, an increase of 8.3% from the previous total of 6,010,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Amylyx Pharmaceuticals' float size? Amylyx Pharmaceuticals currently has issued a total of 68,010,000 shares. Some of Amylyx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amylyx Pharmaceuticals currently has a public float of 46,940,000 shares. How does Amylyx Pharmaceuticals' short interest compare to its competitors? 13.87% of Amylyx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Amylyx Pharmaceuticals: Nuvectis Pharma, Inc. (11.84%), FibroGen, Inc. (5.91%), Syros Pharmaceuticals, Inc. (10.10%), Sagimet Biosciences Inc. (12.02%), PDS Biotechnology Co. (19.47%), DiaMedica Therapeutics Inc. (0.46%), Repare Therapeutics Inc. (2.13%), Karyopharm Therapeutics Inc. (20.23%), Vistagen Therapeutics, Inc. (5.31%), Adicet Bio, Inc. (9.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Amylyx Pharmaceuticals stock? Short selling AMLX is an investing strategy that aims to generate trading profit from Amylyx Pharmaceuticals as its price is falling. AMLX shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amylyx Pharmaceuticals? A short squeeze for Amylyx Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AMLX, which in turn drives the price of the stock up even further. How often is Amylyx Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMLX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Nuvectis Pharma Short Squeeze FibroGen Short Squeeze Syros Pharmaceuticals Short Squeeze Sagimet Biosciences Short Squeeze PDS Biotechnology Short Squeeze DiaMedica Therapeutics Short Squeeze Repare Therapeutics Short Squeeze Karyopharm Therapeutics Short Squeeze Vistagen Therapeutics Short Squeeze Adicet Bio Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMLX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith